This FactSet Research Analyst Turns Bearish; Here Are Top 4 Downgrades For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

• Piper Sandler analyst Crispin Love downgraded the rating for Blackstone Inc. BX from Overweight to Neutral and maintained the price target of $149. Blackstone shares closed at $49.44 on Tuesday. See how other analysts view this stock.
• Maxim Group analyst Naz Rahman downgraded the rating for Virpax Pharmaceuticals, Inc. VRPX from Buy to Hold. Virpax Pharmaceuticals shares closed at $0.4810 on Tuesday. See how other analysts view this stock.
• Daiwa Capital analyst Dennis Ip downgraded Daqo New Energy Corp. DQ from Outperform to Hold, but raised the price target from $18 to $25. Daqo New Energy settled at $20.94 on Tuesday. See how other analysts view this stock.
• Redburn Atlantic analyst Russell Quelch downgraded the rating for FactSet Research Systems Inc. FDS from Neutral to Sell and lowered the price target from $420 to $380. FactSet shares closed at $456.83 on Tuesday. See how other analysts view this stock.

Considering buying BX stock? Here’s what analysts think:

Get Started

Earn 7.2% — No Matter What the Fed Does

Markets expect rate cuts — but your earnings don’t have to suffer. Lock in 7.2% until 2028 from ten individual bonds.

Get Started

Read Next:

• Jim Cramer: AST SpaceMobile Is ‘Just Too Hot,’ Recommends Buying This Tech Stock